Literature DB >> 2186626

Pill-induced esophageal strictures: clinical features and risk factors for development.

G S McCord1, R E Clouse.   

Abstract

Clinical data from five subjects with pill-induced esophageal strictures and from the English-language literature on pill-induced esophageal damage were reviewed to determine risk factors for stricture development and to characterize this complication. Including our five cases, 195 patients with pill-induced damage and 39 patients with pill-induced strictures have been reported to date. Seventy-eight percent of the strictures were located in the proximal or mid-esophagus. Potassium chloride or quinidine preparations were incriminated in 60% of cases and were more likely to produce stricture than other medications commonly associated with esophageal damage (e.g., tetracycline). Older age, male gender, left atrial enlargement, ingestion of sustained-release formulations, and prior esophageal structural abnormality were all more commonly present in the subset with strictures (p less than 0.05 for each), even after appropriately controlling for medication. A logistic regression analysis revealed that older age and ingestion of sustained-release formulations were the most significant independent factors associated with stricture development (p less than 0.0001 for each). These findings indicate that stricture formation from pill-induced esophageal damage is dependent upon host-related factors as well as the caustic nature of the pill.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2186626     DOI: 10.1016/0002-9343(90)90431-c

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

1.  Clinical and endoscopic characteristics of drug-induced esophagitis.

Authors:  Su Hwan Kim; Ji Bong Jeong; Ji Won Kim; Seong-Joon Koh; Byeong Gwan Kim; Kook Lae Lee; Mee Soo Chang; Jong Pil Im; Hyoun Woo Kang; Cheol Min Shin
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 2.  Bioadhesive dosage forms for esophageal drug delivery.

Authors:  Hannah Batchelor
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

Review 3.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

4.  Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.

Authors:  Dorsey M Bass; Mary Prevo; Deborah S Waxman
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 5.  Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management.

Authors:  D Jaspersen
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

Review 6.  Oesophageal mucosal diseases in the elderly.

Authors:  R Ouatu-Lascar; G Triadafilopoulos
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

7.  Gastric secretion of acid and pepsin in patients with esophageal stricture and appropriate controls.

Authors:  B I Hirschowitz
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

Review 8.  Management of refractory and complicated reflux esophagitis.

Authors:  B I Hirschowitz
Journal:  Yale J Biol Med       Date:  1996 May-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.